MCID: CCC002
MIFTS: 52

Coccidiosis

Categories: Infectious diseases, Gastrointestinal diseases

Aliases & Classifications for Coccidiosis

MalaCards integrated aliases for Coccidiosis:

Name: Coccidiosis 12 44 15 73
Intestinal Coccidiosis 12
Enteric Coccidiosis 73

Classifications:



External Ids:

Disease Ontology 12 DOID:2113
MeSH 44 D003048
NCIt 50 C34493
SNOMED-CT 68 186125004 62005008

Summaries for Coccidiosis

Disease Ontology : 12 A parasitic protozoa infectious disease that occurs in the intestinal tract of animals and humans caused by Coccidia protozoa. Immunocompromised persons are at greater risk of developing the infection.

MalaCards based summary : Coccidiosis, also known as intestinal coccidiosis, is related to cryptosporidiosis and alpha chain disease. An important gene associated with Coccidiosis is CD40LG (CD40 Ligand), and among its related pathways/superpathways are Allograft rejection and Influenza A. The drugs Valproic Acid and Fluconazole have been mentioned in the context of this disorder. Affiliated tissues include breast, brain and bone, and related phenotypes are hematopoietic system and liver/biliary system

Wikipedia : 76 Coccidiosis is a parasitic disease of the intestinal tract of animals caused by coccidian protozoa. The... more...

Related Diseases for Coccidiosis

Diseases related to Coccidiosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 317)
# Related Disease Score Top Affiliating Genes
1 cryptosporidiosis 33.0 BFSP2 CD40LG CD79A
2 alpha chain disease 31.2 CD40LG CD79A
3 conjunctivitis 30.3 IFNG IL2 IL4
4 toxoplasmosis 30.3 CD40LG CD79A IFNG IL10 IL4 RHD
5 leishmaniasis 29.5 IFNG IL10 IL4 TLR9 TNF
6 acquired immunodeficiency syndrome 29.4 CD40LG CD79A IFNG IL10 IL2 TNF
7 malaria 27.4 CD40LG IFNG IL10 IL2 IL4 MT-CYB
8 sarcocystosis 11.2
9 coccidioidomycosis 11.2
10 selective igg deficiency disease 11.1 CD40LG CD79A
11 c1q nephropathy 11.1 CD40LG CD79A
12 meningovascular neurosyphilis 11.0 CD40LG CD79A
13 brill-zinsser disease 11.0 CD40LG CD79A
14 exudative glomerulonephritis 11.0 CD40LG CD79A
15 cork-handlers' disease 11.0 CD40LG CD79A
16 salpingo-oophoritis 11.0 CD40LG CD79A
17 early yaws 11.0 CD40LG CD79A
18 ventilation pneumonitis 11.0 CD40LG CD79A
19 chronic interstitial cystitis 11.0 CD40LG CD79A
20 axillary adenitis 11.0 CD40LG CD79A
21 cryofibrinogenemia 11.0 CD40LG CD79A
22 trichostrongyloidiasis 11.0 CD40LG CD79A
23 ross river fever 11.0 CD40LG IL10
24 subacute bacterial endocarditis 11.0 CD40LG CD79A
25 heterophyiasis 11.0 CD40LG CD79A
26 immunoglobulin g deficiency 11.0 CD40LG CD79A
27 orbital granuloma 11.0 CD40LG CD79A
28 transient hypogammaglobulinemia of infancy 11.0 CD40LG CD79A
29 hyperglobulinemic purpura 11.0 CD40LG CD79A
30 gastroduodenitis 11.0 CD40LG CD79A
31 bacterial conjunctivitis 10.9 CD40LG CD79A
32 neuroschistosomiasis 10.9 CD79A IFNG
33 heavy chain disease 10.9 CD40LG CD79A
34 ophthalmia neonatorum 10.9 CD40LG CD79A
35 parotid disease 10.9 CD40LG CD79A
36 punctate inner choroidopathy 10.9 IL10 TNF
37 cerebral arteritis 10.9 CD40LG CD79A
38 oral tuberculosis 10.9 IL2 TNF
39 selective immunoglobulin deficiency disease 10.9 CD40LG CD79A
40 cyclosporiasis 10.9
41 cystoisosporiasis 10.9
42 variola major 10.9 IFNG IL2
43 eye lymphoma 10.9 IL10 TLR9
44 optic papillitis 10.9 CD40LG MRAP
45 acute retinal necrosis syndrome 10.9 CD40LG MRAP
46 ocular toxoplasmosis 10.8 CD40LG CD79A TLR9
47 geniculate herpes zoster 10.8 CD40LG CD79A
48 autoimmune disease of urogenital tract 10.8 CD40LG CD79A TLR9
49 fixed drug eruption 10.8 IFNG IL2
50 mycoplasmal pneumonia 10.8 IFNG IL4

Graphical network of the top 20 diseases related to Coccidiosis:



Diseases related to Coccidiosis

Symptoms & Phenotypes for Coccidiosis

MGI Mouse Phenotypes related to Coccidiosis:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.85 BAG1 CD40LG CD79A IFNG IL10 IL2
2 liver/biliary system MP:0005370 9.5 BAG1 CD79A IFNG IL10 IL2 IL4
3 neoplasm MP:0002006 9.1 BAG1 CD79A IFNG IL10 IL2 TNF

Drugs & Therapeutics for Coccidiosis

Drugs for Coccidiosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 111)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Valproic Acid Approved, Investigational Phase 4 99-66-1 3121
2
Fluconazole Approved, Investigational Phase 4,Phase 3,Not Applicable 86386-73-4 3365
3
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 22916-47-8 4189
4
Levoleucovorin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 68538-85-2
5
Pyrimethamine Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 58-14-0 4993
6
Spiramycin Approved Phase 4,Phase 3,Phase 1,Not Applicable 24916-50-5
7
Sulfadiazine Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 68-35-9 5215
8
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 59-30-3 6037
9
leucovorin Approved, Nutraceutical Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 58-05-9 143 6006
10 Anti-Infective Agents Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
11 Antiparasitic Agents Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
12 Anticonvulsants Phase 4
13 Antimanic Agents Phase 4
14 Central Nervous System Depressants Phase 4
15 GABA Agents Phase 4
16 Neurotransmitter Agents Phase 4,Phase 2
17 Psychotropic Drugs Phase 4,Phase 2
18 Tranquilizing Agents Phase 4
19 Antifungal Agents Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
20 Cytochrome P-450 CYP2C9 Inhibitors Phase 4,Phase 3,Phase 1,Not Applicable
21 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
22 Hormone Antagonists Phase 4,Phase 3,Not Applicable
23 Hormones Phase 4,Phase 3,Not Applicable
24 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Not Applicable
25 Steroid Synthesis Inhibitors Phase 4,Phase 3,Not Applicable
26 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
27 Antidotes Phase 4,Phase 2,Phase 1,Not Applicable
28 Antimalarials Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
29 Antiprotozoal Agents Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
30 Bone Density Conservation Agents Phase 4,Phase 1
31 Calcium, Dietary Phase 4,Phase 2,Phase 1,Not Applicable
32 Folic Acid Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
33 Micronutrients Phase 4,Phase 1
34 Protective Agents Phase 4,Phase 2,Phase 1,Not Applicable
35 Trace Elements Phase 4,Phase 1
36 Vitamin B Complex Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
37 Vitamins Phase 4,Phase 1
38 Folate Nutraceutical Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
39 Vitamin B9 Nutraceutical Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
40
Nitazoxanide Approved, Investigational, Vet_approved Phase 3,Phase 1,Phase 2,Not Applicable 55981-09-4 41684
41
Posaconazole Approved, Investigational, Vet_approved Phase 3 171228-49-2 147912
42
Clotrimazole Approved, Vet_approved Phase 3 23593-75-1 2812
43
Ritonavir Approved, Investigational Phase 3,Phase 2,Phase 1 155213-67-5 392622
44
Sulfamethoxazole Approved Phase 3 723-46-6 5329
45
Trimethoprim Approved, Vet_approved Phase 3 738-70-5 5578
46 Anti-HIV Agents Phase 3,Phase 2,Phase 1
47 Anti-Retroviral Agents Phase 3,Phase 2,Phase 1
48 Antiviral Agents Phase 3,Phase 2,Phase 1
49 Atazanavir Sulfate Phase 3,Phase 1
50 Cytochrome P-450 CYP3A Inhibitors Phase 3,Phase 2,Phase 1

Interventional clinical trials:

(show top 50) (show all 63)
# Name Status NCT ID Phase Drugs
1 Pilot Trial of Valproate as Adjunctive Treatment for Toxoplasma Gondii Infection in Early Course Schizophrenia Completed NCT02011750 Phase 4 Sodium Valproate treatment;Placebo
2 Efficacy Study of Fluconazole to Treat Coccidioidomycosis Pneumonia (Valley Fever) Recruiting NCT02663674 Phase 4 Fluconazole
3 Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis Recruiting NCT00004317 Phase 4 Leucovorin calcium;Pyrimethamine;Spiramycin;Sulfadiazine
4 Assessment of Two Therapeutic Strategies in the Treatment of Children With Congenital Toxoplasmosis Unknown status NCT01202500 Phase 3
5 POS vs FLU for First Line Treatment of Coccidioidomycosis (Study P04558Am1)(COMPLETED) Completed NCT00423267 Phase 3 Posaconazole;Fluconazole
6 A Multi-center Study of Spherule-Derived Coccidioidin Completed NCT00690092 Phase 3
7 Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081) Completed NCT00000676 Phase 3 Clotrimazole;Fluconazole
8 PRINCE: Study of Atazanavir (ATV)/Ritonavir (RTV) Completed NCT01099579 Phase 3 Atazanavir powder;Ritonavir oral solution;Atazanavir capsules;Ritonavir capsules
9 Prevention of Congenital Toxoplasmosis With Pyrimethamine + Sulfadiazine Versus Spiramycine During Pregnancy Completed NCT01189448 Phase 3 Pyrimethamine/Sulfadiazine;Spiramycine
10 Influence of Trimethoprim-Sulfamethoxazole for the Recurrence of Ocular Toxoplasmosis Completed NCT01449877 Phase 3 Trimethoprim-Sulfamethoxazole
11 Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients Terminated NCT00004986 Phase 3 Nitazoxanide
12 Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine Completed NCT00415051 Phase 2
13 Safety and Immunogenicity Study of Rift Valley Fever Vaccine Completed NCT00584194 Phase 2
14 Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants Completed NCT00289185 Phase 2
15 Double-blind Study of Safety and Immunogenicity of Two Candidate Malaria Vaccines in Gabonese Children Completed NCT00307021 Phase 2
16 Nitazoxanide for the Treatment of Chronic Diarrhea in HIV Infected Children Completed NCT00055107 Phase 1, Phase 2 Nitazoxanide
17 A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by Cryptosporidium Completed NCT00001081 Phase 2 Nitazoxanide
18 Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis Completed NCT00000794 Phase 2 Sulfadiazine;Clarithromycin;Atovaquone;Pyrimethamine;Leucovorin calcium
19 A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3 Completed NCT00000771 Phase 2 Paromomycin sulfate
20 Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected Patients Completed NCT00000643 Phase 2 Pyrimethamine;Leucovorin calcium
21 A Phase 2A Evaluation of the Safety, Tolerability, Pharmacokinetics, Efficacy of Clofazimine (CFZ) in Cryptosporidiosis Recruiting NCT03341767 Phase 2 Clofazimine;Placebo
22 Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated Enrolling by invitation NCT00869713 Phase 2
23 Sertraline in Addition to Standard of Care Treatment for Coccidioidomycosis Not yet recruiting NCT02908334 Phase 2 Sertraline
24 Safety and PK of Nikkomycin Z for Coccidioides Pneumonia Treatment Terminated NCT00614666 Phase 1, Phase 2 nikkomycin Z
25 Interleukin 12 (IL-12) for the Treatment of Cryptosporidiosis in AIDS Patients Terminated NCT00057486 Phase 1, Phase 2 IL-12
26 Dose-finding Study of GSK2248761 in Antiretroviral Therapy-experienced Subjects With NNRTI-resistant HIV Infection Terminated NCT01199731 Phase 2 GSK2248761 100 mg once daily;GSK2248761 200 mg once daily;Etravirine
27 Phase I Study of Pyrimethamine in Healthy Japanese and Caucasian Subjects Completed NCT03258762 Phase 1 Pyrimethamine;Calcium folinate
28 Antiretroviral Drug Interaction Study in Volunteers With HIV Completed NCT01479361 Phase 1 Atovaquone 750 mg twice daily;Atovaquone 1500 mg twice daily
29 A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Trial of the Efficacy and Safety of Bovine Anti-Cryptosporidium Immunoglobulin (BACI) in the Treatment of Cryptosporidium Enteritis in AIDS Patients Completed NCT00002248 Phase 1 Cryptosporidium Immune Whey Protein Concentrate (Bovine)
30 A Study of Letrazuril in the Treatment of AIDS-Related Diarrhea Completed NCT00001018 Phase 1 Letrazuril
31 A Study of Spiramycin in the Treatment of Patients With AIDS-Related Diarrhea Completed NCT00000980 Phase 1 Spiramycin
32 A Study of Pyrimethamine in the Treatment of Infection by a Certain Parasite in HIV-Positive Patients Completed NCT00000973 Phase 1 Pyrimethamine;Leucovorin calcium;Zidovudine
33 A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients With AIDS Completed NCT00000966 Phase 1 Azithromycin;Pyrimethamine;Leucovorin calcium
34 A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis Unknown status NCT00002158 Not Applicable Nitazoxanide
35 Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis Completed NCT00796809
36 Rift Valley Fever in Kenya Completed NCT00287014
37 A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common Completed NCT00002325 Not Applicable Fluconazole
38 Open, Non-Comparative Study of Fluconazole in Patients With Coccidioidal Meningitis Completed NCT00002010 Not Applicable Fluconazole
39 HIV Cohort Study At Johns Hopkins University, University of North Carolina at Chapel Hill and Vanderbilt University Completed NCT01339416
40 Cerebral Toxoplasmosis and AIDS Completed NCT00803621
41 Evaluation of Biological Biomarkers Diagnostic of Toxoplasmosis Uveitis Completed NCT02843438 Not Applicable Anti-toxoplasmosis treatment;Anti-inflammatory treatments
42 Breast Milk Composition and HIV-exposed/Unexposed Early Infant Growth and Infectious Disease Events Completed NCT01699841
43 Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya Completed NCT01695304 Not Applicable
44 Transmission and the Respiratory Tract in Cryptosporidiosis Completed NCT00507871
45 Intravitreal Bevacizumab in Recalcitrant Inflammatory Ocular Neovascularization Completed NCT00645697
46 Azithromycin in the Treatment of Cryptosporidiosis in Patients Who Have Not Had Success With Other Drugs Completed NCT00002328 Not Applicable Azithromycin
47 A 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients With AIDS Completed NCT00002278 Not Applicable Diclazuril
48 The Effectiveness of Cow's Milk Immune Globulin in the Treatment of AIDS-Related Diarrhea Completed NCT00002264 Not Applicable Cryptosporidium Immune Whey Protein Concentrate (Bovine)
49 Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind Study Completed NCT00002082 Not Applicable Azithromycin
50 Toxoplasmic Encephalitis in Patients With AIDS. Treatment and Prevention of Relapse Completed NCT00002064 Not Applicable Pyrimethamine;Clindamycin

Search NIH Clinical Center for Coccidiosis

Cochrane evidence based reviews: coccidiosis

Genetic Tests for Coccidiosis

Anatomical Context for Coccidiosis

MalaCards organs/tissues related to Coccidiosis:

41
Breast, Brain, Bone, T Cells, Liver, Small Intestine, Testes

Publications for Coccidiosis

Articles related to Coccidiosis:

(show top 50) (show all 582)
# Title Authors Year
1
The impact of I^-glucans on performance and response of broiler chickens during a coccidiosis challenge. ( 29897525 )
2018
2
A review of coccidiosis in water buffaloes (Bubalus bubalis). ( 29887030 )
2018
3
Effects of in ovo injection of different doses of coccidiosis vaccine and turn-out times on broiler performance,. ( 29462434 )
2018
4
Chicken Coccidiosis in Central Java, Indonesia: A Recent Update. ( 29593858 )
2018
5
Coccidiosis in Large and Small Ruminants. ( 29249601 )
2018
6
Effects of tannic acid extract on performance and intestinal health of broiler chickens following coccidiosis vaccination and/or a mixed-species Eimeria challenge. ( 29767789 )
2018
7
The use of a live non-attenuated coccidiosis vaccine modifies Eimeria spp. excretion in commercial antibiotic-free broiler chicken flocks compared to conventional shuttle anticoccidial programs. ( 29897515 )
2018
8
EVALUATION OF THE ANTIGENICITY AND IMMUNOGENICITY OF <i>Eimeria tenella</i> BY REPRODUCTIVE INDEX AND HISTOPATHOLOGICAL CHANGES OF CECAL COCCIDIOSIS VIRULENT LIVE VACCINE IN BROILER CHICKENS. ( 29619439 )
2018
9
Use of discriminant analysis for the evaluation of coccidiosis resistance parameters in chickens raised in hot humid tropical environment. ( 29464539 )
2018
10
A review of coccidiosis in South American camelids. ( 29804192 )
2018
11
Investigations on the Occurrence and Associated Risk Factors of Avian Coccidiosis in Osun State, Southwestern Nigeria. ( 29138693 )
2017
12
Potential Vaccine Targets against Rabbit Coccidiosis by Immunoproteomic Analysis. ( 28285502 )
2017
13
Coccidiosis control. ( 28550233 )
2017
14
Evaluation of amprolium and toltrazuril efficacy in controlling natural intestinal rabbit coccidiosis. ( 29163644 )
2017
15
Effects of feeding Original XPCa8c to broilers with a live coccidiosis-vaccine under industry conditions: Part 1. Growth performance and Salmonella inhibition. ( 28340000 )
2017
16
Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis. ( 28867614 )
2017
17
DETECTION OF INTRANUCLEAR COCCIDIOSIS IN TORTOISES IN EUROPE AND CHINA. ( 28749291 )
2017
18
Inclusion of Bacillus amyloliquefaciens strain TOA5001 in the diet of broilers suppresses the symptoms of coccidiosis by modulating intestinal microbiota. ( 29282825 )
2017
19
Coccidiosis of domestic pigeons (Columba livia domestica Gmelin, 1789) in Kano State, Nigeria ( 29274213 )
2017
20
Treatment against coccidiosis in Norwegian lambs and potential risk factors for development of anticoccidial resistance-a questionnaire-based study. ( 28190155 )
2017
21
Effects of coccidiosis vaccination administered by in ovo injection on Ross 708 broiler performance through 14 days of post-hatch age. ( 28339834 )
2017
22
Coccidiosis in European rabbit (Oryctolagus cuniculus algirus) populations in the Iberian Peninsula. ( 28030335 )
2017
23
Effects of feeding Original XPCa8c to broilers with a live coccidiosis vaccine under industrial conditions: Part 2. Cecal microbiota analysis. ( 28339832 )
2017
24
EXTENSION OF THE KNOWN HOST RANGE OF INTRANUCLEAR COCCIDIOSIS: INFECTION IN THREE CAPTIVE RED-FOOTED TORTOISES ( CHELONOIDIS CARBONARIA). ( 29297806 )
2017
25
Epicellular coccidiosis in goldfish. ( 28627487 )
2017
26
Pathology in Practice. Severe intestinal coccidiosis in a chicken. ( 28671500 )
2017
27
Effects of coccidiosis vaccination administered by in ovo injection on the hatchability and hatching chick quality of broilers. ( 27794546 )
2016
28
Anticoccidial effect of Piper sarmentosum extracts in experimental coccidiosis in broiler chickens. ( 26984597 )
2016
29
Simple and noninvasive method for assessment of digestive efficiency: Validation of fecal steatocrit in greenfinch coccidiosis model. ( 28035266 )
2016
30
Beneficial Effect of Bidens pilosa on Body Weight Gain, Food Conversion Ratio, Gut Bacteria and Coccidiosis in Chickens. ( 26765226 )
2016
31
Prevention of coccidiosis in dairya8^cows. ( 27084611 )
2016
32
Coccidiosis in European rabbit (Oryctolagus cuniculus algirus) populations in the Iberian Peninsula. ( 27447236 )
2016
33
Assessment of risk factors associated with prevalence of coccidiosis in dairy animals of Punjab. ( 27876948 )
2016
34
Evaluation of furazolidone, sulfadimidine and amprolium to treat coccidiosis in beetal goats under field conditions. ( 27087093 )
2016
35
Liver mitochondrial oxygen consumption and proton leak kinetics in broilers supplemented with dietary copper or zinc following coccidiosis challenge. ( 27544066 )
2016
36
Study on impression smears of hepatic coccidiosis in rabbits. ( 27605807 )
2016
37
Three operational taxonomic units of Eimeria are common in Nigerian chickens and may undermine effective molecular diagnosis of coccidiosis. ( 27259544 )
2016
38
Combination of probiotics and coccidiosis vaccine enhances protection against an Eimeria challenge. ( 27825377 )
2016
39
Disease surveillance of Atlantic herring: molecular characterization of hepatic coccidiosis and a morphological report of a novel intestinal coccidian. ( 27409233 )
2016
40
Anticoccidial effect of mananoligosacharide against experimentally induced coccidiosis in broiler. ( 27068898 )
2016
41
Synergistic approach for treatment of chicken coccidiosis using berberine - A plant natural product. ( 26802524 )
2016
42
Susceptibility of Broiler Chickens to Coccidiosis When Fed Subclinical Doses of Deoxynivalenol and Fumonisins-Special Emphasis on the Immunological Response and the Mycotoxin Interaction. ( 27472362 )
2016
43
Dynamic Patterns of Systemic Innate Immunity and Inflammatory Associated Factors in Experimental Caprine Coccidiosis. ( 28095656 )
2016
44
Prevalence of Coccidiosis in Free-Range Chicken in Sidi Thabet, Tunisia. ( 27213084 )
2016
45
Immune protection duration and efficacy stability of DNA vaccine encoding Eimeria tenella TA4 and chicken IL-2 against coccidiosis. ( 27914219 )
2016
46
The effect of sainfoin (Onobrychis viciifolia) and carob pods (Ceratonia siliqua) feeding regimes on the control of lamb coccidiosis. ( 26920568 )
2016
47
Prevention of coccidiosis in dairya8^cows. ( 27084612 )
2016
48
Prevalence of coccidiosis among village and exotic breed of chickens in Maiduguri, Nigeria. ( 27397991 )
2016
49
Herbal Remedies for Coccidiosis Control: A Review of Plants, Compounds, and Anticoccidial Actions. ( 27429634 )
2016
50
Coccidiosis in the Chukar Partridge ( Alectoris chukar ): A Survey of Coccidiosis Outbreaks and a Test of Anticoccidial Drugs Against Eimeria kofoidi. ( 27902917 )
2016

Variations for Coccidiosis

Expression for Coccidiosis

Search GEO for disease gene expression data for Coccidiosis.

Pathways for Coccidiosis

Pathways related to Coccidiosis according to GeneCards Suite gene sharing:

(show all 36)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.82 CD40LG IFNG IL10 IL2 IL4 TNF
2
Show member pathways
12.74 IFNG IL2 IL4 TLR9 TNF
3
Show member pathways
12.72 CD79A IFNG IL2 IL4 TLR9 TNF
4
Show member pathways
12.58 IFNG IL10 IL2 IL4 TNF
5
Show member pathways
12.44 IFNG IL2 IL4 TNF
6
Show member pathways
12.38 IFNG IL10 IL2 IL4 TNF
7
Show member pathways
12.38 CD40LG IFNG IL10 IL2 IL4 TNF
8
Show member pathways
12.28 IFNG IL2 IL4 TNF
9
Show member pathways
12.22 IFNG IL10 IL2 TLR9 TNF
10
Show member pathways
12.21 CD40LG IFNG IL10 IL4 TNF
11 12.19 IFNG IL10 TLR9 TNF
12
Show member pathways
12.16 IL10 IL2 TLR9 TNF
13
Show member pathways
12.12 IFNG IL4 TLR9 TNF
14 12.07 CD40LG CD79A IFNG IL10 IL2 IL4
15 11.96 IFNG IL2 IL4 TNF
16 11.9 IL10 IL4 TNF
17
Show member pathways
11.89 IFNG IL2 IL4
18 11.82 IFNG IL10 TNF
19 11.74 IFNG IL2 IL4
20 11.71 IFNG IL10 IL2 IL4 TNF
21 11.7 CD79A IFNG IL10 IL2 IL4 TNF
22
Show member pathways
11.65 CD40LG IFNG IL2 IL4 TNF
23 11.62 CD40LG IL10 IL4
24
Show member pathways
11.62 CD40LG IFNG IL2 TNF
25
Show member pathways
11.6 IFNG IL2 TNF
26 11.59 IFNG IL10 IL2 TLR9 TNF
27 11.51 IFNG IL2 TNF
28 11.48 IL10 IL4 TNF
29 11.47 IFNG IL2 TNF
30 11.47 IFNG IL10 IL2 IL4
31 11.34 CD40LG IFNG IL10 TLR9 TNF
32 11.32 IFNG IL10 TLR9 TNF
33 11.28 CD40LG IFNG IL2 IL4
34 11.27 IFNG IL4 TNF
35 11.15 IFNG IL10 IL2 IL4
36 10.5 IFNG IL10 IL2 IL4 TNF

GO Terms for Coccidiosis

Biological processes related to Coccidiosis according to GeneCards Suite gene sharing:

(show all 27)
# Name GO ID Score Top Affiliating Genes
1 cytokine-mediated signaling pathway GO:0019221 9.93 IL10 IL2 IL4 TNF
2 defense response to bacterium GO:0042742 9.88 IL10 LEAP2 TLR9 TNF
3 positive regulation of T cell proliferation GO:0042102 9.73 CD40LG IL2 IL4
4 positive regulation of B cell proliferation GO:0030890 9.65 IL2 IL4 TLR9
5 positive regulation of membrane protein ectodomain proteolysis GO:0051044 9.63 IFNG TNF
6 immune response GO:0006955 9.63 CD40LG IFNG IL10 IL2 IL4 TNF
7 regulation of regulatory T cell differentiation GO:0045589 9.62 IFNG IL2
8 negative regulation of growth of symbiont in host GO:0044130 9.62 IL10 TNF
9 response to molecule of bacterial origin GO:0002237 9.61 IL10 TLR9
10 positive regulation of heterotypic cell-cell adhesion GO:0034116 9.61 IL10 TNF
11 positive regulation of isotype switching to IgG isotypes GO:0048304 9.59 IL2 IL4
12 endothelial cell apoptotic process GO:0072577 9.58 IL10 TNF
13 B cell proliferation GO:0042100 9.58 CD40LG CD79A IL10
14 positive regulation of MHC class II biosynthetic process GO:0045348 9.57 IL10 IL4
15 negative regulation of cytokine secretion involved in immune response GO:0002740 9.55 IL10 TNF
16 type 2 immune response GO:0042092 9.54 IL10 IL4
17 negative regulation of interleukin-8 production GO:0032717 9.52 IL10 TLR9
18 regulation of immunoglobulin secretion GO:0051023 9.51 CD40LG TNF
19 negative regulation of interleukin-6 production GO:0032715 9.5 IL10 TLR9 TNF
20 regulation of isotype switching GO:0045191 9.49 IL10 IL4
21 receptor biosynthetic process GO:0032800 9.46 IL10 TNF
22 positive regulation of calcidiol 1-monooxygenase activity GO:0060559 9.43 IFNG TNF
23 positive regulation of interleukin-12 production GO:0032735 9.43 CD40LG IFNG TLR9
24 regulation of signaling receptor activity GO:0010469 9.43 CD40LG IFNG IL10 IL2 IL4 TNF
25 positive regulation of vitamin D biosynthetic process GO:0060557 9.37 IFNG TNF
26 B cell differentiation GO:0030183 8.92 CD40LG CD79A IL10 IL4
27 negative regulation of apoptotic process GO:0043066 10 BAG1 CD40LG IL10 IL2 IL4

Molecular functions related to Coccidiosis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.1 CD40LG IFNG IL10 IL2 IL4 TNF

Sources for Coccidiosis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....